( en | de | ru )

 

Disambiguation of "Brookhart, M Alan"

Author of the publication

copydeleteadd this publication to your clipboard
Doubly robust estimation of causal effects.

, , , , , and . American journal of epidemiology, 173 (7): 761-7 (April 2011)6075<br/>JID: 7910653; aheadofprint;<br/><br/>Causalitat; Propensity score; IPTW.
DOI: 10.1093/aje/kwq439

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Safwat Alani

Maia Alandjiyska

Yilmaz Alan

Bertold Aland

Viola Alanku

 

Other publications of authors with the same name

A SAS macro for a clustered logrank test., , , , , and . Comput. Methods Programs Biomed., 104 (2): 266-270 (2011)Instrumental variable methods in comparative safety and effectiveness research., , and . Pharmacoepidemiology and drug safety, 19 (6): 537-54 (June 2010)5676<m:linebreak></m:linebreak>GR: 1 K01 HS018088/HS/AHRQ HHS/United States; GR: 290-2005-0016-I-TO3-WA1/PHS HHS/United States; GR: K25AG027400/AG/NIA NIH HHS/United States; JID: 9208369; NIHMS205457; OID: NLM: NIHMS205457 Available on 06/01/11; OID: NLM: PMC2886161 Available on 06/01/11; ppublish;<m:linebreak></m:linebreak>Variables instrumentals.Primary non-adherence and the new-user design., , , and . Pharmacoepidemiology and drug safety, 27 (4): 361-364 (April 2018)Adherence; New-user designs; Bias.Evolving statistical methods to facilitate evaluation of the causal association between erythropoiesis-stimulating agent dose and mortality in nonexperimental research: strengths and limitations., , , , , , , , , and . American journal of kidney diseases : the official journal of the National Kidney Foundation, 54 (3): 554-60 (September 2009)5279<m:linebreak></m:linebreak>JID: 8110075; 0 (Hematinics); RF: 40; 2008/12/19 received; 2009/05/06 accepted; 2009/07/09 aheadofprint; ppublish;.Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy., , , , , , and . Pharmacoepidemiology and drug safety, 22 (8): 810-8 (August 2013)Propensity score; Oncologia.Propensity score methods for confounding control in nonexperimental research., , , and . Circulation. Cardiovascular quality and outcomes, 6 (5): 604-11 (September 2013)Propensity score; Introductori; CV; SAS.A semiparametric model selection criterion with applications to the marginal structural model., and . Comput. Stat. Data Anal., 50 (2): 475-498 (2006)Doubly robust estimation of causal effects., , , , , and . American journal of epidemiology, 173 (7): 761-7 (April 2011)6075<br/>JID: 7910653; aheadofprint;<br/><br/>Causalitat; Propensity score; IPTW.Preference-based instrumental variable methods for the estimation of treatment effects: assessing validity and interpreting results., and . The international journal of biostatistics, 3 (1): Article 14 (January 2007)5028<m:linebreak></m:linebreak>Variables instrumentals.Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable., , , and . Epidemiology (Cambridge, Mass.), 17 (3): 268-75 (May 2006)4043<m:linebreak></m:linebreak>Variables instrumentals.